Literature DB >> 11175376

The long-term effects of pre-treatment with activated protein C in a rat model of compression-induced spinal cord injury.

Y Taoka1, M G Schlag, R Hopf, H Redl.   

Abstract

OBJECTIVES: Recently, we demonstrated that activated protein C (APC) can lessen the severity of spinal cord injury (SCI) in rats during the acute and subacute phases. The purpose of the present study is to determine the long-term effects of pre-treatment with APC following SCI in rats.
METHODS: The motor function of rats was assessed using the inclined-plane test during 8 weeks after SCI, and the grid runway test 7 weeks after the trauma. Somatosensory evoked potentials (SEPs), brainstem-derived motor evoked potentials (B-MEPs) and corticomotor evoked potentials (CMEPs) were used to quantify axonal function 8 weeks after SCI. Morphometric analysis of the spinal cord lesion was carried out to determine lesion size. Twelve male Sprague-Dawley rats were randomly allocated to either APC (25 IU/kg) or saline group and then subjected to 20 g compression injury of the spinal cord for 20 min at T12. The sham group (n=6) received laminectomy alone.
RESULTS: APC significantly reduced the motor disturbances and electrophysiological impairments induced by SCI. APC-treated animals also showed a trend towards a reduction in lesion size. However, this change, was not significant.
CONCLUSION: Pre-treatment with APC attenuates the harmful effects of SCI not only during the acute and subacute phases but also in the chronic stage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175376     DOI: 10.1038/sj.sc.3101096

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  5 in total

1.  Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity.

Authors:  Yaoming Wang; Meenakshisundaram Thiyagarajan; Nienwen Chow; Itender Singh; Huang Guo; Thomas P Davis; Berislav V Zlokovic
Journal:  Stroke       Date:  2008-12-04       Impact factor: 7.914

2.  Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model.

Authors:  Gregory O'Connor; Elisabeth Jeffrey; Derik Madorma; Alexander Marcillo; Maria T Abreu; Sapna K Deo; W Dalton Dietrich; Sylvia Daunert
Journal:  J Neurotrauma       Date:  2018-06-07       Impact factor: 5.269

3.  Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke.

Authors:  Patricia D Williams; Berislav V Zlokovic; John H Griffin; Kent E Pryor; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity.

Authors:  Huang Guo; Yaoming Wang; Itender Singh; Dong Liu; José A Fernández; John H Griffin; Nienwen Chow; Berislav V Zlokovic
Journal:  J Neurochem       Date:  2009-01-23       Impact factor: 5.372

5.  Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity.

Authors:  Huang Guo; Itender Singh; Yaoming Wang; Rashid Deane; Theresa Barrett; José A Fernández; Nienwen Chow; John H Griffin; Berislav V Zlokovic
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.